Evidence map›Paper›PMID 32670826›Full record

ReviewJournal of traditional and complementary medicine2020

Luca Colucci-D'Amato, Gloria Cimaglia

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of traditional and complementary medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. International journal of molecular sciences · 2024
    Article
  2. Article
  3. Traditional Uses, Phytochemistry, Pharmacology and Toxicology ofDrug design, development and therapy · 2024
    Review
  4. Antioxidants (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Journal of traditional and complementary medicine · 2022
    Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Luca Colucci-D'AmatoDepartment of Environmental, Biological and Pharmaceutical Science and Technology (DiSTABiF), University of Campania "L. Vanvitelli", Caserta, Italy.
Gloria CimagliaSchool of Optometry and Vision Sciences, Cardiff University, Cardiff, UK.
Karolinska Institutet · SEUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nutraceuticals had always been known for their therapeutic effects in ancient medicine and had been the primary healing remedy until the introduction of modern chemistry and pharmacology. However, their use has not been dismissed but actually is acquiring a new acclamation among the scientific community especially for their efficacy on the Central Nervous System (CNS). Molecular mechanisms of the most common neurodegenerative diseases are now being uncovered and along with that the molecules that drive the neurodegenerative processes. It is not surprising that some natural compounds can interact with those molecules and interfere with the pathological pathways halting the cascades that ultimately lead to neuronal cell death. The plant

Indexed as

GlioblastomaNatural compoundsNeural plasticityNeurodegenerationRuta graveolens

Identifiers

PMID32670826
PMCPMC7340976
OpenAlexW3034127526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.